1
Return

TRIM24 in Human Cancers: A Dual-Function Oncoprotein, Regulatory Mechanisms, and Emerging Therapeutic Strategies

delete2026-06-15
delete0
PRE
AI
W
Wenjie Zeng
K
Keke Xu
Y
Yuezhou Wang
Y
Yiyi Shou
H
Hao Xiong
L
Lanqing Liang
H
Hong'en Xu
R
Ruiqi Liu *
H
Haibo Zhang *
Y
Yanwei Lu *
DOI:10.1002/ijc.70565delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The tripartite motif-containing protein 24 (TRIM24) functions as a pivotal epigenetic scaffold and E3 ubiquitin ligase, orchestrating tumorigenesis through context-dependent dual roles. While frequently amplified in cancers such as prostate and breast carcinoma—where it drives oncogenesis via Wnt/β-catenin and PI3K/AKT pathway activation—emerging evidence positions TRIM24 as a tumor suppressor in specific contexts, modulating retinoic acid signaling and macrophage polarization. This dichotomy is governed by intricate post-translational modifications (PTMs), including phosphorylation-dependent nucleocytoplasmic shuttling and SUMOylation, which dictate substrate specificity for targets ranging from p53 to VHL. Furthermore, TRIM24 operates within a complex non-coding RNA network (e.g., miRNA-511, lncRNA NCK1-AS1) that fine-tunes its oncogenic output. Clinically, aberrant TRIM24 expression correlates with poor prognosis and therapeutic resistance across multiple malignancies. Mechanistically, its unique PHD-Bromo dual-domain structure confers specific recognition of the noncanonical H3K4me0/H3K23ac histone signature, presenting a compelling therapeutic target. Current strategies, including PROTAC degraders and allosteric inhibitors targeting its bromodomain or downstream effectors (e.g., DNA-PKcs, AURKB), demonstrate significant preclinical efficacy. This review synthesizes the molecular circuitry of TRIM24, elucidates the determinants of its functional switch, and evaluates emerging precision medicine approaches to overcome resistance in TRIM24-addicted tumors.
Keywords:
cancer
E3 ubiquitin ligase
oncogene
therapeutic target
TRIM24

Journal

International Journal of Cancer cover
International Journal of Cancer
IF:
4.7
Papers:
2.0W
Citations:
4.9W

Organization

Z
Zhejiang Provincial People's Hospital
Scholars:
779
Papers: 330
Citations: 4.1K
Z
zhejiang chinese medical university
Scholars:
4.2K
Papers: 1.4K
Citations: 0
W
wenzhou medical university
Scholars:
6.2K
Papers: 1.6K
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers